Kalaris Therapeutics, Inc. (KLRS)

Kalaris Therapeutics Statistics

Total Valuation

KLRS has a market cap or net worth of $110.06 million. The enterprise value is $34.61 million.

Market Cap	110.06M
Enterprise Value	34.61M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

KLRS has 18.70 million shares outstanding. The number of shares has increased by 514.28% in one year.

Current Share Class	18.70M
Shares Outstanding	18.70M
Shares Change (YoY)	+514.28%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	9.02%
Owned by Institutions (%)	9.51%
Float	4.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.63
P/TBV Ratio	2.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.89, with a Debt / Equity ratio of 0.04.

Current Ratio	12.89
Quick Ratio	12.70
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.09

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-63.50%
Return on Invested Capital (ROIC)	-572.13%
Return on Capital Employed (ROCE)	-56.56%
Revenue Per Employee	n/a
Profits Per Employee	-$3.96M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	5.55
200-Day Moving Average	n/a
Relative Strength Index (RSI)	52.85
Average Volume (20 Days)	161,590

Short Selling Information

The latest short interest is 428,091, so 2.29% of the outstanding shares have been sold short.

Short Interest	428,091
Short Previous Month	403,085
Short % of Shares Out	2.29%
Short % of Float	9.25%
Short Ratio (days to cover)	1.12

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-42.48M
Pretax Income	-55.47M
Net Income	-55.47M
EBITDA	n/a
EBIT	-42.48M
Earnings Per Share (EPS)	-$3.46

Balance Sheet

The company has $77.00 million in cash and $1.55 million in debt, giving a net cash position of $75.45 million or $4.03 per share.

Cash & Cash Equivalents	77.00M
Total Debt	1.55M
Net Cash	75.45M
Net Cash Per Share	$4.03
Equity (Book Value)	41.87M
Book Value Per Share	2.24
Working Capital	72.12M

Cash Flow

In the last 12 months, operating cash flow was -$39.16 million and capital expenditures -$183,000, giving a free cash flow of -$39.35 million.

Operating Cash Flow	-39.16M
Capital Expenditures	-183,000
Free Cash Flow	-39.35M
FCF Per Share	-$2.10

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KLRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-514.28%
Shareholder Yield	-514.28%
Earnings Yield	-50.39%
FCF Yield	-35.75%

Analyst Forecast

The average price target for KLRS is $21.50, which is 265.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.50
Price Target Difference	265.34%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-15.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2